首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical pediatric endocrinology

缩写:

ISSN:0918-5739

e-ISSN:1347-7358

IF/分区:1.0/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引556
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Masanori Adachi Masanori Adachi
Hematopoietic stem cell transplantation (HSCT)-associated partial lipodystrophy (HSCT-PL) is a serious metabolic complication that develops in remote period among childhood cancer survivors treated with HSCT with total body irradiation (TBI...
Anjana Hulse,Priya Ranganath Anjana Hulse
Concerns regarding linear growth and dysmorphic features are common in several genetic syndromes. Among these, PTHLH-related brachydactyly type E (BDE), which is inherited in an autosomal dominant manner, is a rare but distinct genetic diso...
Yusuke Kamoda,Nanako Kawata,Emina Ubukata et al. Yusuke Kamoda et al.
Hypophosphatasia (HPP) is a rare osteometabolic disease. Enzyme replacement therapy (ERT) for HPP was approved in 2015 and has significantly improved the survival and quality of life of patients. Poor responses to ERT have been reported; ho...
Joana Azevedo Silva,Ana Rita A Costa,Inês Mazeda et al. Joana Azevedo Silva et al.
Hypophosphatasia (HPP) is a rare inherited metabolic bone disorder caused by pathogenic variants in the ALPL gene, with a wide clinical spectrum ranging from severe pediatric forms to mild adult-onset disease. In contrast, heterozygous vari...
Ignazio Cammisa,Donato Rigante,Clelia Cipolla Ignazio Cammisa
Central precocious puberty (CPP) results from the premature activation of the hypothalamic-pituitary-gonadal (HPG) axis. Although the GnRH stimulation test remains the gold standard for diagnosis, the uterine artery pulsatility index (PI) h...
Megumi Endo,Shuntaro Morikawa,Naoya Kaneko et al. Megumi Endo et al.
In recent years, the use of immune checkpoint inhibitors (ICIs) and tyrosine kinase inhibitors (TKIs) has increased and has demonstrated excellent antitumor effects. However, immunotherapy in pediatric patients remains limited, and knowledg...